Seed VC · San Francisco

1955 Capital

Active

What they invest in

1955 Capital focuses on the translational gap between scientific discovery and company building, investing before markets are obvious in breakthrough technologies across biology, materials, and computation. The firm works closely with founders and scientists to turn early discoveries into real companies.

Who they back

Climate TechEnergyFood and agritechManufacturing and circular economyTransport and mobilityEducationHealth and femtechSeedSeries A

Business models

deeptech_ip, hardware, biotech_therapeutics

Customer segments

Enterprise, Healthcare Providers, Industrial, Government

Geography

US

Recent investments

  • Nature's Fynd
  • Noah Medical
  • Gridtential

+ 3 more deals. Score your deck to see the full investment history.

The people who write checks

1 partners on file at 1955 Capital, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

1955 Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. Claude Fundraiser tracks 1955 Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Website
www.1955.capital

Other firms investing in Climate Tech

See all investors →

Is 1955 Capital the right fit for your deck?

Drop your pitch. Claude scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. 1955 Capital is one of them — and we'll tell you exactly where they sit in your top 100.